Can the use of extracellular vesicles and anti-CD38 nanobodies help in the fight against multiple myeloma? That’s the question NabGen Technology and a consensus of researchers are trying to answer.
Can the use of extracellular vesicles and anti-CD38 nanobodies help in the fight against multiple myeloma? That’s the question NabGen Technology and a consensus of researchers are trying to answer.